Middle East SARS spike S1 recombinant protein product blog
Tags: Recombinant Protein; Middle East SARS spike S1; Middle East SARS spike S1 recombinant protein;
The CoV-MERS n/a (Catalog #MBS596077) is a Recombinant Protein produced from E Coli and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s CoV-MERS spike-RBD can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunoassay (IA). Researchers should empirically determine the suitability of the CoV-MERS n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. The amino acid sequence is listed below:EAKPSGSVVE QAEGVECDFS PLLSGTPPQV YNFKRLVFTN CNYNLTKLLS LFSVNDFTCS QISPAAIASN CYSSLILDYF SYPLSMKSDL SVSSAGPISQ FNYKQSFSNP TCLILATVPH NLTTITKLKY SYINKCSRLL SDDRTEVPQL VNANQYSPCV SIVPSTVWED GDYYRKQLSP LEGGGWLVAS GSTVAMTEQL QMGFGITVQY GTDTNSVCPK LEFANDTKIA SQLGNCVEY.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given recombinant protein. We\'ve tested the CoV-MERS spike-RBD with the following immunoassay(s):
Testing Data (Sequence)
SDS-PAGE
SDS-PAGE (SDS)
Our knowledge of the role of proteins in cellular processes is continually evolving. Most proteins, including CoV-MERS spike-RBD are typically involved in one or more signaling pathways or biological processes. Professionally manufactured recombinant proteins are increasingly becoming essential and commonplace tools for elucidating new knowledge about the role of proteins in both health and disease.
Important Note: Centrifuge before opening to ensure complete recovery of vial contents.